Department of Hygiene and Technology of Food of Animal Origin, School of Veterinary Medicine, Aristotle University of Thessaloniki, Thessaloniki 54006, Greece.
Enzyme Microb Technol. 2012 Aug 10;51(3):125-30. doi: 10.1016/j.enzmictec.2012.04.007. Epub 2012 May 22.
The present work describes a novel central pathway engineering method that has been designed with the aim to increase the carbon conversion rates under oxidizing conditions in L. lactis fermentations. The nisin producer L. lactis ATCC11454 strain has been genetically engineered by cloning a truncated version of the phosphofructokinase gene (pfk13), along with the pkaC, encoding for the catalytic subunit of cAMP-dependent protein kinase, and the alternative oxidase (aox1) genes of A. niger. Functional expression of the above genes resulted in enhanced PFK activity and the introduction of AOX activity and alternative respiration in the presence of a source of heme in the substrate, under fully aerobic growth conditions. The constructed strain is capable of fermenting high concentrations of glucose as was demonstrated in a series of glucostat fed-batch fermentations with glucose levels maintained at 55, 138 and 277 mM. The high maximum specific uptake rate of glucose of 1.8 mMs(-1)gCDW(-1) at 277 mM glucose is characteristic of the improved ability of the microorganism to handle elevated glucose concentrations under conditions otherwise causing severe reduction of PFK activity. The increased carbon flow through glycolysis led to increased protein synthesis that was reflected in increased biomass and nisin levels. The pfk 13-pkaC-aox1-transformant strain's fermentation at 277 mM glucose gave a final biomass concentration of 7.5 g/l and nisin activity of 14,000 IU/ml which is, compared to the parental strain's production levels at its optimal 55 mM glucose, increased by a factor of 2.34 for biomass and 4.37 for nisin.
本工作描述了一种新颖的中心途径工程方法,旨在提高乳酸乳球菌发酵过程中氧化条件下的碳转化率。通过克隆磷酸果糖激酶基因(pfk13)的截断版本,以及编码 cAMP 依赖性蛋白激酶催化亚基的 pkaC 和黑曲霉的交替氧化酶(aox1)基因,对乳链球菌生产纳豆激酶的 ATCC11454 菌株进行了基因工程改造。上述基因的功能表达导致 PFK 活性增强,并在底物中有血红素源的情况下引入 AOX 活性和替代呼吸,在完全需氧生长条件下。该构建菌株能够发酵高浓度的葡萄糖,这在一系列以葡萄糖为基质的葡萄糖恒化器分批发酵中得到了证明,葡萄糖浓度维持在 55、138 和 277mM。在 277mM 葡萄糖下,葡萄糖的最大比摄取率高达 1.8mMs(-1)gCDW(-1),这是微生物在其他情况下导致 PFK 活性严重降低的情况下处理高浓度葡萄糖的能力提高的特征。通过糖酵解增加的碳流导致蛋白质合成增加,这反映在生物量和乳链菌肽水平的增加上。pfk13-pkaC-aox1 转化株在 277mM 葡萄糖下发酵,最终生物量浓度达到 7.5g/l,乳链菌肽活性达到 14000IU/ml,与亲本菌株在其最佳 55mM 葡萄糖下的生产水平相比,生物量提高了 2.34 倍,乳链菌肽提高了 4.37 倍。